Innovotech, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA45772U1049
CAD
0.20
-0.01 (-2.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1245216,
    "name": "Innovotech, Inc.",
    "stock_name": "Innovotech, Inc.",
    "full_name": "Innovotech, Inc.",
    "name_url": "stocks-analysis/innovotech-inc",
    "exchange": 32,
    "exchangecode": "TSX",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "0.20",
    "chg": -0.01,
    "chgp": "-2.38%",
    "dir": -1,
    "prev_price": "0.21",
    "mcapval": "12.43",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P/TSX 60",
    "isin": "CA45772U1049",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "18.0 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innovotech-inc-1245216-32&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Innovotech Reports Significant Profit Growth Amid Positive Valuation Shift",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innovotech-upgraded-to-hold-as-valuation-score-improves-significantly-3626429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InnovotechInc_mojoScore_3626429.png",
        "date": "2025-10-16 17:14:30",
        "description": "Innovotech, Inc. has recently seen a positive adjustment in its evaluation, reflecting a notable improvement in its financial performance. The company reported significant growth in quarterly profits and operating cash flow, while its stock has outperformed the S&P/TSX 60 index over the past year."
      },
      {
        "title": "Innovotech Experiences Mixed Technical Signals Amid Valuation Adjustment in Biotechnology Sector",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innovotech-stock-downgraded-from-hold-to-sell-amid-mixed-performance-indicators-3565603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/InnovotechInc_mojoScore_3565603.png",
        "date": "2025-09-24 14:58:25",
        "description": "Innovotech, Inc. has undergone a recent evaluation adjustment, reflecting changes in its technical and valuation metrics. The company's technical indicators show mixed signals, while its valuation remains attractive despite a non-applicable P/E ratio due to losses. Key metrics include a Price to Book Value of 4.43 and an EV to Sales ratio of 2.81."
      },
      {
        "title": "Innovotech, Inc. Adjusts Valuation Amid Mixed Technical Indicators and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innovotech-inc-stock-rating-adjusted-from-sell-to-hold-amid-valuation-upgrade-3526021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/InnovotechInc_mojoScore_3526021.png",
        "date": "2025-09-17 15:56:18",
        "description": "Innovotech, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a notable adjustment in its evaluation metrics, indicating a shift in its valuation. The company's financial landscape remains complex, with mixed technical indicators suggesting a nuanced market position amid ongoing adjustments."
      }
    ],
    "total": 3,
    "sid": "1245216",
    "stock_news_url": "https://www.marketsmojo.com/news/innovotech-inc-1245216"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available